Clinical Trial Patient Recruitment Services Market To Reach $22.85 Billion By 2033

November 2025 | Report Format: Electronic (PDF)

Clinical Trial Patient Recruitment Services Market Growth & Trends

The global clinical trial patient recruitment services market size is estimated to reach USD 22.85 billion by 2033, expanding at a CAGR of 8.72% from 2025 to 2033, according to a new report by Grand View Research, Inc. The growing pharmaceutical and medical sectors, increasing demand for clinical studies, and adoption of decentralized clinical trials are a few of the factors supporting the growth of the clinical trial patient recruitment services market.

However, the COVID-19 pandemic has affected the global market, the outbreak of COVID-19 has caused a voluntary pause in the clinical trials across the globe. The temporary lockdown has significantly disrupted clinical trials, especially in the patient recruitment industry. The lockdown has restricted the patient’s visits to trial sites, which has ultimately led to significant dropouts of the patient population from several clinical trials.

However, companies operating across the industry have focused on mitigating the negative impact of the pandemic by adopting measures such as mergers and acquisitions, implementation of digital technologies such as decentralized clinical trials, remote monitoring of patients, and a few others. Such factors helped the industry to flourish back to its normal growth rate post-2021.

Pharmaceutical organizations are progressively focusing on R&D activities to remain competitive & flexible in the world of healthcare expertise. Companies are focusing on outsourcing tasks ranging from basic research to patient enrollment services. Digital methods of communication are one of the most recent trends witnessed across the patient recruitment services market.

With the help of online platforms, the recruitment growth seems to be streamlining. The majority of people learn about clinical trials through online sources compared to traditional print or TV/radio outreach. Hence, several e-recruitment tactics are evolving, such as social media, web listening, as well as online screeners.

In addition, with the increasing usage of mobile devices, the use of smartphone applications and text messaging has become more widespread. For instance, in North America, about 11% of clinical studies involve social media communications. Hence, the aforementioned factors are anticipated to support the growth of the market.

key Request a free sample copy or view report summary: Clinical Trial Patient Recruitment Services Market Report

Clinical Trial Patient Recruitment Services Market Report Highlights

On the basis of phase segment, in 2024, phase III held the largest revenue share due to the large-scale participant requirements and complex study designs.
On the basis of service, in 2024, patient recruitment & registry services segment held the largest market share in the market, accounting for a revenue share of 68.01%.
On the basis of therapeutic area segment, the oncology segment dominated the market in 2024. This is because the cost related to pain management is significantly higher than in other therapeutic areas, thus simultaneously increasing the fees for patient recruitment and retention services
In terms of age group, the adult (18 - 64 Years) segment is expected to witness a considerable growth rate across the forecast timeframe, owing to the increasing prevalence of health conditions in the age group
North America held the largest share of 50.50% in 2024. The market is expected to grow significantly, driven by the region's substantial number of ongoing clinical trials.

Clinical Trial Patient Recruitment Services Market Segmentation

Grand View Research has segmented the global clinical trial patient recruitment services market based on service, phase, therapeutic area, age group and region:

Clinical Trial Patient Recruitment Services Service Outlook (Revenue, USD Million, 2021 - 2033)

Patient recruitment & registry services
Patient retention services
Others

Clinical Trial Patient Recruitment Services Phase Outlook (Revenue, USD Million, 2021 - 2033)

Phase I
Phase II
Phase III
Phase IV

Clinical Trial Patient Recruitment Services Therapeutic Area Outlook (Revenue, USD Million, 2021 - 2033)

Respiratory diseases
Pain and anesthesia
Oncology
Central nervous system
Cardiovascular
Endocrine
Anti-infective
Others

Clinical Trial Patient Recruitment Services Age Group Outlook (Revenue, USD Million, 2021 - 2033)

Child (birth-17 years)
Adult (18 - 64 years)
Older adults (65 years+)

Clinical Trial Patient Recruitment Services Regional Outlook (Revenue, USD Million, 2021 - 2033)

North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- China
- India
- Thailand
- South Korea
- Australia
Latin America
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
- Oman
- Qatar